Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Measles-Rubella Vaccine at 6 and 9 Months
NCT03071575Phase 4Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Mar 2017
- Primary completion
- Mar 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Measles and Rubella Vaccine (PT Bio Farma) in measles, rubella, sponsored by Centers for Disease Control and Prevention. Started Mar 2017; status: completed.
02
Drugs
Measles and Rubella Vaccine (PT Bio Farma)
03
Conditions
measlesrubella
Beyond the preview
Go deeper on NCT03071575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03071575.